Clinical Trial Update: Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing a combination of oxomemazine, guaifenesin, and potassium iodate versus guaifenesin alone for acute cough shows completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• Guaifenesin monotherapy (guaifenesin)
• Oxomemazine, guaifenesin, and potassium iodate combination

Snippet

Sponsor: EMS | Conditions: Cough | Phase 3 | Status: COMPLETED